List of Tables
Table 1. Global Small Molecule αIIbβ3 Antagonists Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Small Molecule αIIbβ3 Antagonists Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Small Molecule αIIbβ3 Antagonists Market Competitive Situation by Manufacturers in 2025
Table 4. Global Small Molecule αIIbβ3 Antagonists Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Small Molecule αIIbβ3 Antagonists Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Small Molecule αIIbβ3 Antagonists Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Small Molecule αIIbβ3 Antagonists Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Small Molecule αIIbβ3 Antagonists, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Small Molecule αIIbβ3 Antagonists, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Small Molecule αIIbβ3 Antagonists, Product Types and Applications
Table 12. Global Key Manufacturers of Small Molecule αIIbβ3 Antagonists, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Small Molecule αIIbβ3 Antagonists Companies by Tier (Tier 1, Tier 2, Tier 3), based on Small Molecule αIIbβ3 Antagonists Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Small Molecule αIIbβ3 Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Small Molecule αIIbβ3 Antagonists Sales by Region (K Units), 2021–2026
Table 18. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Region (2021–2026)
Table 19. Global Small Molecule αIIbβ3 Antagonists Sales by Region (K Units), 2027–2032
Table 20. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Region (2027–2032)
Table 21. Global Small Molecule αIIbβ3 Antagonists Revenue by Region (US$ Million), 2021–2026
Table 22. Global Small Molecule αIIbβ3 Antagonists Revenue Market Share by Region (2021–2026)
Table 23. Global Small Molecule αIIbβ3 Antagonists Revenue by Region (US$ Million), 2027–2032
Table 24. Global Small Molecule αIIbβ3 Antagonists Revenue Market Share by Region (2027–2032)
Table 25. North America Small Molecule αIIbβ3 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2021–2026
Table 27. North America Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2027–2032
Table 28. North America Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 29. North America Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Small Molecule αIIbβ3 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2021–2026
Table 32. Europe Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2027–2032
Table 33. Europe Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Small Molecule αIIbβ3 Antagonists Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Small Molecule αIIbβ3 Antagonists Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Small Molecule αIIbβ3 Antagonists Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Small Molecule αIIbβ3 Antagonists Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Small Molecule αIIbβ3 Antagonists Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Small Molecule αIIbβ3 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2021–2026
Table 42. Latin America Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2027–2032
Table 43. Latin America Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Small Molecule αIIbβ3 Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Small Molecule αIIbβ3 Antagonists Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Small Molecule αIIbβ3 Antagonists Revenue by Country (US$ Million), 2027–2032
Table 50. Global Small Molecule αIIbβ3 Antagonists Sales (K Units) by Type (2021–2026)
Table 51. Global Small Molecule αIIbβ3 Antagonists Sales (K Units) by Type (2027–2032)
Table 52. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Type (2021–2026)
Table 53. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Type (2027–2032)
Table 54. Global Small Molecule αIIbβ3 Antagonists Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Small Molecule αIIbβ3 Antagonists Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Small Molecule αIIbβ3 Antagonists Revenue Market Share by Type (2021–2026)
Table 57. Global Small Molecule αIIbβ3 Antagonists Revenue Market Share by Type (2027–2032)
Table 58. Global Small Molecule αIIbβ3 Antagonists Price (US$/Unit) by Type (2021–2026)
Table 59. Global Small Molecule αIIbβ3 Antagonists Price (US$/Unit) by Type (2027–2032)
Table 60. Global Small Molecule αIIbβ3 Antagonists Sales (K Units) by Application (2021–2026)
Table 61. Global Small Molecule αIIbβ3 Antagonists Sales (K Units) by Application (2027–2032)
Table 62. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Application (2021–2026)
Table 63. Global Small Molecule αIIbβ3 Antagonists Sales Market Share by Application (2027–2032)
Table 64. Global Small Molecule αIIbβ3 Antagonists Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Small Molecule αIIbβ3 Antagonists Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Small Molecule αIIbβ3 Antagonists Revenue Market Share by Application (2021–2026)
Table 67. Global Small Molecule αIIbβ3 Antagonists Revenue Market Share by Application (2027–2032)
Table 68. Global Small Molecule αIIbβ3 Antagonists Price (US$/Unit) by Application (2021–2026)
Table 69. Global Small Molecule αIIbβ3 Antagonists Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Small Molecule αIIbβ3 Antagonists Product
Table 74. Merck Recent Developments/Updates
Table 75. Correvio Company Information
Table 76. Correvio Description and Business Overview
Table 77. Correvio Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Correvio Small Molecule αIIbβ3 Antagonists Product
Table 79. Correvio Recent Developments/Updates
Table 80. Medicure Company Information
Table 81. Medicure Description and Business Overview
Table 82. Medicure Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Medicure Small Molecule αIIbβ3 Antagonists Product
Table 84. Medicure Recent Developments/Updates
Table 85. Bio-Thera Solutions Company Information
Table 86. Bio-Thera Solutions Description and Business Overview
Table 87. Bio-Thera Solutions Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bio-Thera Solutions Small Molecule αIIbβ3 Antagonists Product
Table 89. Bio-Thera Solutions Recent Developments/Updates
Table 90. Gland Pharma
Taj Pharmaceuticals Company Information
Table 91. Gland Pharma
Taj Pharmaceuticals Description and Business Overview
Table 92. Gland Pharma
Taj Pharmaceuticals Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Gland Pharma
Taj Pharmaceuticals Small Molecule αIIbβ3 Antagonists Product
Table 94. Gland Pharma
Taj Pharmaceuticals Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. GlaxoSmithKline Small Molecule αIIbβ3 Antagonists Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Takeda Company Information
Table 101. Takeda Description and Business Overview
Table 102. Takeda Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Takeda Small Molecule αIIbβ3 Antagonists Product
Table 104. Takeda Recent Developments/Updates
Table 105. Hybio Pharmaceutical Company Information
Table 106. Hybio Pharmaceutical Description and Business Overview
Table 107. Hybio Pharmaceutical Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Hybio Pharmaceutical Small Molecule αIIbβ3 Antagonists Product
Table 109. Hybio Pharmaceutical Recent Developments/Updates
Table 110. Lunan Pharma Company Information
Table 111. Lunan Pharma Description and Business Overview
Table 112. Lunan Pharma Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Lunan Pharma Small Molecule αIIbβ3 Antagonists Product
Table 114. Lunan Pharma Recent Developments/Updates
Table 115. Kelun Pharma Company Information
Table 116. Kelun Pharma Description and Business Overview
Table 117. Kelun Pharma Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Kelun Pharma Small Molecule αIIbβ3 Antagonists Product
Table 119. Kelun Pharma Recent Developments/Updates
Table 120. Grand Pharmaceutical Company Information
Table 121. Grand Pharmaceutical Description and Business Overview
Table 122. Grand Pharmaceutical Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Grand Pharmaceutical Small Molecule αIIbβ3 Antagonists Product
Table 124. Grand Pharmaceutical Recent Developments/Updates
Table 125. Tianjin Chase Sun Pharma Company Information
Table 126. Tianjin Chase Sun Pharma Description and Business Overview
Table 127. Tianjin Chase Sun Pharma Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Tianjin Chase Sun Pharma Small Molecule αIIbβ3 Antagonists Product
Table 129. Tianjin Chase Sun Pharma Recent Developments/Updates
Table 130. SJZ No.4 Pharmaceutical Company Information
Table 131. SJZ No.4 Pharmaceutical Description and Business Overview
Table 132. SJZ No.4 Pharmaceutical Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. SJZ No.4 Pharmaceutical Small Molecule αIIbβ3 Antagonists Product
Table 134. SJZ No.4 Pharmaceutical Recent Developments/Updates
Table 135. Huadong Medicin Company Information
Table 136. Huadong Medicin Description and Business Overview
Table 137. Huadong Medicin Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Huadong Medicin Small Molecule αIIbβ3 Antagonists Product
Table 139. Huadong Medicin Recent Developments/Updates
Table 140. Nanjing King-Friend Company Information
Table 141. Nanjing King-Friend Description and Business Overview
Table 142. Nanjing King-Friend Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Nanjing King-Friend Small Molecule αIIbβ3 Antagonists Product
Table 144. Nanjing King-Friend Recent Developments/Updates
Table 145. Chengdu Shengnuo Biotechnology Company Information
Table 146. Chengdu Shengnuo Biotechnology Description and Business Overview
Table 147. Chengdu Shengnuo Biotechnology Small Molecule αIIbβ3 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Chengdu Shengnuo Biotechnology Small Molecule αIIbβ3 Antagonists Product
Table 149. Chengdu Shengnuo Biotechnology Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Small Molecule αIIbβ3 Antagonists Distributors List
Table 153. Small Molecule αIIbβ3 Antagonists Customers List
Table 154. Small Molecule αIIbβ3 Antagonists Market Trends
Table 155. Small Molecule αIIbβ3 Antagonists Market Drivers
Table 156. Small Molecule αIIbβ3 Antagonists Market Challenges
Table 157. Small Molecule αIIbβ3 Antagonists Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Small Molecule αIIbβ3 Antagonists
Figure 2. Global Small Molecule αIIbβ3 Antagonists Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Small Molecule αIIbβ3 Antagonists Market Share by Type: 2025 & 2032
Figure 4. Tirofiban Product Picture
Figure 5. Eptifibatide Product Picture
Figure 6. Bevifibatide Product Picture
Figure 7. Global Small Molecule αIIbβ3 Antagonists Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Small Molecule αIIbβ3 Antagonists Market Share by Application: 2025 & 2032
Figure 9. Percutaneous Coronary Intervention (PCI)
Figure 10. Acute Coronary Syndrome (ACS)
Figure 11. Other
Figure 12. Global Small Molecule αIIbβ3 Antagonists Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Small Molecule αIIbβ3 Antagonists Market Size (US$ Million), 2021–2032
Figure 14. Global Small Molecule αIIbβ3 Antagonists Sales (K Units), 2021–2032
Figure 15. Global Small Molecule αIIbβ3 Antagonists Average Price (US$/Unit), 2021–2032
Figure 16. Small Molecule αIIbβ3 Antagonists Report Years Considered
Figure 17. Small Molecule αIIbβ3 Antagonists Sales Share by Manufacturers in 2025
Figure 18. Global Small Molecule αIIbβ3 Antagonists Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Small Molecule αIIbβ3 Antagonists Players: Market Share by Revenue in Small Molecule αIIbβ3 Antagonists in 2025
Figure 20. Small Molecule αIIbβ3 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Small Molecule αIIbβ3 Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Small Molecule αIIbβ3 Antagonists Sales Market Share by Country (2021–2032)
Figure 23. North America Small Molecule αIIbβ3 Antagonists Revenue Market Share by Country (2021–2032)
Figure 24. United States Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Small Molecule αIIbβ3 Antagonists Sales Market Share by Country (2021–2032)
Figure 27. Europe Small Molecule αIIbβ3 Antagonists Revenue Market Share by Country (2021–2032)
Figure 28. Germany Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Small Molecule αIIbβ3 Antagonists Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Small Molecule αIIbβ3 Antagonists Revenue Market Share by Region (2021–2032)
Figure 35. China Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Small Molecule αIIbβ3 Antagonists Sales Market Share by Country (2021–2032)
Figure 43. Latin America Small Molecule αIIbβ3 Antagonists Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Small Molecule αIIbβ3 Antagonists Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Small Molecule αIIbβ3 Antagonists Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Small Molecule αIIbβ3 Antagonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Small Molecule αIIbβ3 Antagonists by Type (2021–2032)
Figure 54. Global Revenue Market Share of Small Molecule αIIbβ3 Antagonists by Type (2021–2032)
Figure 55. Global Small Molecule αIIbβ3 Antagonists Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Small Molecule αIIbβ3 Antagonists by Application (2021–2032)
Figure 57. Global Revenue Market Share of Small Molecule αIIbβ3 Antagonists by Application (2021–2032)
Figure 58. Global Small Molecule αIIbβ3 Antagonists Price (US$/Unit) by Application (2021–2032)
Figure 59. Small Molecule αIIbβ3 Antagonists Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
